Medline Inc.

MDLNNASDAQHealthcare● Active

$33.19

$-0.43(-1.26%)

Market Cap$28.1B

P/E Ratio—

52W High$50.876

52W Low$32.815

Avg Volume9.4M

Open$33.52

Beta-0.24

Overview

Medline Inc. (MDLN) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

MDLN · free cash flow · updated Jun 8, 2026

Core FCF metrics

MDLN · FCF · TTM · margin & CAGR

Free cash flow was $1.74B for FY2025 (fiscal year ending 2025-12-31), up 24.1% year-over-year The FCF margin was 6.1%.

FY2025 Free Cash Flow$1.74B▲ +24.1% YoY

Trailing 12M (TTM)$1.52Btrailing 4 quarters sum

FCF Margin6.1%$1.74B ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

MDLN · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$1.74B(0M)$1.74B▲ +24.1%6.1%

FY2024$1.77B(364M)$1.41B▲ +0.4%5.5%

FY2023$1.69B(285M)$1.40B▲ +2189.6%6.0%

FY2022$187.0M(254M)−$67.0M—-0.3%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

MDLN · P/FCF · FCF yield · FCF per share

Medline Inc. (MDLN) trades at a FCF yield of 5.37% and a price-to-free-cash-flow ratio of 17.7x. FCF per share stands at $1.88, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

5.37%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$1.88

TTM FCF ÷ Shares Outstanding

Price / FCF

x17.7

Share Price ÷ FCF per Share

EV / FCF (TTM)

x25.4

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

MDLN · cash flow statement · operating / investing / financing

For FY2025, Medline Inc. generated $1.74B in operating cash flow and spent 0M in capital expenditures, yielding $1.74B in free cash flow.

Operating Activities

+$1.74B

Cash from core business operations

2025-12-31

Investing Activities

−$474.0M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$399.0M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($1.74B) − |CapEx| (0M) = FCF ($1.74B)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

MDLN vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Medline Inc.YOU

MDLN

$1.74B+24.1%6.1%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Medline Inc. (MDLN) reported free cash flow of $1.74B for FY2025 (fiscal year ending 2025-12-31), up 24.1% year-over-year. The FCF margin was 6.1%.

Based on available data, Medline Inc. has maintained positive free cash flow for at least 3 fiscal year(s). FCF peaked at $1.74B in FY2025.

Medline Inc.'s FCF yield is 5.37% and price-to-FCF ratio is 17.7x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

MDLN free cash flow · 8 questions

Medline Inc. free cash flow was $1.74B for FY2025, up 24.1% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $1.52B.

MDLN free cash flowMDLN FCFMDLN FCF 2025MDLN free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Medline Inc. · Medline Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026